Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC
Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC aliu Wed, 01/31/2024 - 15:12
Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC aliu Wed, 01/31/2024 - 15:12
Teva's refresh under new CEO Richard Francis moves into year 2 as Austedo, Ajovy and generics gain steam fkansteiner Wed, 01/31/2024 - 14:23
FDA slams Eugia with Form 483 and posts older reprimands for AGC, Baxter jkeenan Wed, 01/31/2024 - 12:50
Novo Nordisk doubles stock of Wegovy starter doses, but supply constraints persist: CEO fkansteiner Wed, 01/31/2024 - 11:06
In continuing its transformation, Teva confirms plan to sell off API business kdunleavy Wed, 01/31/2024 - 10:50
After Novartis' radiotherapy Pluvicto disappoints, CEO touts 'compelling case' for future growth aliu Wed, 01/31/2024 - 10:33
GSK confirms Arexvy is a blockbuster but says the RSV battle has just begun kdunleavy Wed, 01/31/2024 - 09:10
Biogen abandons Aduhelm efforts, focuses on Eisai-partnered Leqembi and pipeline drugs esagonowsky Wed, 01/31/2024 - 08:12
FDA rejects Defender Pharma's motion sickness nasal gel candidate kdunleavy Tue, 01/30/2024 - 16:24
As AstraZeneca gears up for courtroom showdown over IRA, Novo's case faces separate HHS rebuke fkansteiner Tue, 01/30/2024 - 16:11